<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>4</Volume>
				<Issue>2(spring)</Issue>
				<PubDate PubStatus="epublish">
					<Year>2005</Year>
					<Month>06</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Vitamin A Supplementary Effect on Immunologic Profiles in Tuberculosis Patients</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>53</FirstPage>
			<LastPage>60</LastPage>
			<ELocationID EIdType="pii">241462</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Somayeh</FirstName>
					<LastName>Mohammadian</LastName>
<Affiliation>Department of Nutrition, Tabriz University of Medical Sciences and Health Services</Affiliation>

</Author>
<Author>
					<FirstName>Jalil</FirstName>
					<LastName>Baghdadchi</LastName>
<Affiliation>Department of Nutrition, Tabriz University of Medical Sciences and Health Services</Affiliation>

</Author>
<Author>
					<FirstName>Ali Reza</FirstName>
					<LastName>Ostad Rahimi</LastName>
<Affiliation>Department of Nutrition, Tabriz University of Medical Sciences and Health Services</Affiliation>

</Author>
<Author>
					<FirstName>Shahpour</FirstName>
					<LastName>Shahghasempour</LastName>
<Affiliation>Department of Infectious Diseases</Affiliation>

</Author>
<Author>
					<FirstName>Majid</FirstName>
					<LastName>Valiollahpour Amiri</LastName>
<Affiliation>Department of Infectious Diseases</Affiliation>

</Author>
<Author>
					<FirstName>Foroozan</FirstName>
					<LastName>Mohammadi</LastName>
<Affiliation>Department
of Clinical Anatomical Pathology,</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Mehdi</FirstName>
					<LastName>Mirsaiedi</LastName>
<Affiliation>Department of Infectious Diseases,</Affiliation>

</Author>
<Author>
					<FirstName>Ali Akbar</FirstName>
					<LastName>Velayati</LastName>
<Affiliation>Department of Pediatrics, NRITLD, Shaheed Beheshti University of Medical Sciences and Health
Services.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>01</Month>
					<Day>05</Day>
				</PubDate>
			</History>
		<Abstract>Background: The effects of vitamins on human immune system have been well studied. Vitamin A deficiency and its effects on immune system in pulmonary tuberculosis (TB) patients have been established. This study was carried out to evaluate vitamin A supplementary effect on immunologic profile of tuberculosis patients. Materials and Methods: In a double-blind clinical trial, thirty-five patients with confirmed pulmonary tuberculosis were included. The case group received vitamin A injection, 50000 lU, every 10 days for two months along with standard treatment of TB; the control group received only anti-TB drugs. Immunologic profiles including CD3+, CD4+, CD8+, CD4+/CD8+, CD19+, HLA-DR, CD16+56+, and plasma vitamin A as well as nutritional status were assessed in both groups primarily and two months after above-mentioned treatments. Data were analysed using SPSS software version 10. Results: The study showed that there were not significant differences in mean(± SD) of age, body weight, height, body mass index (BMI), fat thickness and vitamin A plasma level between the vit A-receiving and control groups. The mean of peripheral blood CD3+ showed significant increase in patient-control group [71.8 ±7.9 % lymphocytes (after supplementation) compared with 68.3 ±10.7% (before supplementation); p= 0.014.]. This was also true about CD4+ (p= 0.001). CD4+ to CD8+ ratio and the mean of CD19+ showed significant decrease in the patient control group and the vit A-receiving group, respectively (p= 0.002 and p= 0.04, respectively). In contrast, there was an increased significant difference for CD+16+56+ mean in the above-mentioned groups which was more prominent in the vit A- receiving group (p=0.038). The means of HLA-DR and CD8+ did not show significant differences in both groups before and after supplementation. Conclusion: It seems that vitamin A supplementary effects on the quality of lymphocytic markers are remarkable. However, further studies should be performed regarding immunologic response quality. (Tanaffos 2005; 4(14):53-60)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">tuberculosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Vit A supplementation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Immunologic profile</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_241462_4f30cdd6c317cf21f769dc461f0faa2e.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
